Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 14
Submit an article Journal homepage
112
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms

Charles Gaulina Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6943-4614View further author information
ORCID Icon,
Fiona Craigb Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Shannon Fortin Ensigna Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Ryan Robetoryeb Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Sarah Gibsonb Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Katalin Kelemenb Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Nandita Kheraa Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Jose Leisa Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Mazie Tsanga Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Allison Rosenthala Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Javier Munoza Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USAView further author information
,
Jeanne Palmera Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USAView further author information
&
Talal Hilala Department of Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USAView further author information
 show all
Pages 2347-2350 | Received 29 Jul 2023, Accepted 31 Aug 2023, Published online: 07 Sep 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

Dr. Gaulin reports personal fees from DeciBio, personal fees from ADC Therapeutics, outside the submitted work. Dr. Craig has nothing to disclose. Dr. Fortin Ensign has nothing to disclose. Dr. Robetorye has nothing to disclose. Dr. Gibson has nothing to disclose. Dr. Kelemen has nothing to disclose. Dr. Khera has nothing to disclose. Dr. Leis has nothing to disclose. Dr. Tsang has nothing to disclose. Dr. Rosenthal has nothing to disclose. Dr. Munoz reports grants and personal fees from Pharmacyclics/Abbvie, grants and personal fees from Bayer, grants and personal fees from Gilead/Kite Pharma, personal fees from Pfizer, grants and personal fees from Janssen, personal fees from Juno/Celgene, personal fees from BMS, personal fees from Kyowa, personal fees from Alexion, personal fees from Fosun kite, personal fees from lnnovent, grants and personal fees from Seattle Genetics, personal fees from Debiopharm, personal fees from Karyopharm, personal fees from Genmab, personal fees from ADC Therapeutics, personal fees from Epizyme, personal fees from BeiGene, personal fees from Servier, personal fees from Novartis, personal fees from Morphosys/lncyte, personal fees from Secura Bio, personal fees from TG Therapeutics, personal fees from MEI, personal fees from Lilly/Loxo, grants from Celgene, grants from Merck, grants from Portola, grants from lncyte, grants from Genentech, grants from Millennium, personal fees from Targeted Oncology, personal fees from OncView, personal fees from Curio, personal fees from Physicians’ Education Resource, personal fees from Pharmacyclics/Janssen, personal fees from Acrotech/Aurobindo, personal fees from Pharmacyclics, personal fees from Verastem, personal fees from AstraZeneca, personal fees from Celgene/BMS, personal fees from Genentech/Roche, outside the submitted work. Dr. Palmer has nothing to disclose. Dr. Hilal has nothing to disclose.

Data availability statement

The data that support the findings of this study are available upon reasonable request.

Additional information

Funding

This research received no external funding.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.